Le. Wagoner, MANAGEMENT OF THE CARDIAC TRANSPLANT RECIPIENT - ROLES OF THE TRANSPLANT CARDIOLOGIST AND PRIMARY-CARE PHYSICIAN, The American journal of the medical sciences, 314(3), 1997, pp. 173-184
Cardiac transplantation has become an accepted treatment for selected
patients with end-stage heart failure. Despite a successful transplant
, denervated transplanted hearts respond differently to cardiac drugs
than nontransplanted hearts. The treatments for bradycardia, tachycard
ia, and hypotension are different than for nontransplanted hearts. Des
pite the improvement in long-term survival, a number of complications
may occur posttransplantation. These complications include, allograft
rejection, infection, allograft coronary artery disease, and malignanc
y. Additionally, posttransplant patients may have complications from t
he immunosuppressive agents cyclosporine, prednisione, and azathioprin
e. Such complications include drug interactions with commonly prescrib
ed medications, hypertension, hyperlipidemia, osteoporosis, and gastro
intestinal complications. The. purpose of this article is to discuss t
he management of the cardiac transplant recipient as it relates to the
aforementioned complications. Management of the cardiac transplantati
on patient by the primary care physician will also be discussed, inclu
ding indications for consultation by the primary care physician with t
he transplant center.